Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lexaria Bioscience Corp. LEXX

Alternate Symbol(s):  LEXXW

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 
@ the Bell: Energy & mining recover to lift TSX
Following a nasty session in the red, Canada’s main stock index rose more than 300 points in Friday trading. Gains were led by the energy and base metal sectors.After two brutal weeks brought... read article.
The Cannabis Report: June 24, 2022
Nextleaf to launch THC-O as an excise tax-free alternative to Delta-9-THC Nextleaf Solutions (OILS) has provided an update on the manufacturing of D9-tetrahydrocannabinol acetate,... read article.
Buzz on the Bullboards: Another summer of uncertainty?
In times of uncertainty in the markets, investors tend to focus on more consistent plays.Not all investors are basking in summer vacations and backyard barbeques. For those who are still plugged... read article.

RE:RE:RE:RE:RE:REMEMBER when AGpicks (eg pumper) liked lexx?

Another great press to scale across USA  rate and reply

RE:RE:RE:RE:RE:RE:REMEMBER when AGpicks (eg pumper) liked lexx?

ITs like YEAH nothingness news and the stock is up .55 now, we all bought at $6 ot higher we are still down 70%! BUT foggetabout we are up .55! YAHOO!!!!!!!!!!! NOOBIES!!!!!!!!!!!  rate and reply

RE:RE:RE:RE:RE:REMEMBER when AGpicks (eg pumper) liked lexx?

its okay dehyratach (+50 other names) you have ranman and a few others they are noob as noob can be they will continue to lose everything but you got'm reeled in  rate and reply

New Press Release - Lexaria Signs Manufacturing and License Agreements with BevNology

(TheNewswire) Expands DehydraTECH™ B2B manufacturing capabilities to support Lexaria’s growing corporate customer baseLexaria to also receive royalty revenue from DehydraTECH product sales through BevNology’s commercial license rightsKelowna, British Columbia – TheNewswire - June 21, 2022...read article.

RE:RE:RE:RE:REMEMBER when AGpicks (eg pumper) liked lexx?

Wakeup you think this company a scam It's clear you have no idea how biotechs investments need plenty of Data inputs to get real licensing deals in place Fwiw do you also know it takes a B2B...read more

Looks to me we decoupled from markets

Lexaria dehydratech less is same or more Great fir inflationary times in regards to inputs per dose IND forthcoming and I expect that many pharma giants will come and fund #Dehydratech_CBD for any...read more

New Press Release - Lexaria Grants License to AnodGen Bioceuticals

DehydraTECH Pharmaceutical License Issued for the European, Australian and New Zealand marketsLexaria to receive royalty revenue from DehydraTECH product salesKELOWNA, BC / ACCESSWIRE / June 8, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global...read article.

RE:RE:RE:REMEMBER when AGpicks (eg pumper) liked lexx?

hey ranman do you not know who i am yet? Do you remember totally hip software?  I made the news in stockwatch several times, before the CEO was fired, and the stock failed.    too bad...read more

New Press Release - Lexaria Files Pre-IND Meeting Request Letter with U.S. FDA

(TheNewswire) Kelowna, British Columbia – TheNewswire - June 6, 2022 – Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to announce it has successfully filed a pre-Investigational New Drug (“IND...read article.

Bigger deals are going to start

Japan and Europe will put eyes on us more seriously now If all the cards line up We could be looking a a dividend paying stock in 2 years especially if we get a partner to pay all R&D for CBD fda...read more

RE:RE:REMEMBER when AGpicks (eg pumper) liked lexx?

you are so so sad ranman :( 20 YEARS and still as noob as noob can be NO HOpE for you, hopefully there is for others #1 rule is, DO not follow AGpumper or you lose 50-90+% per play, INCULDING lexx ...read more

RE:REMEMBER when AGpicks (eg pumper) liked lexx?

Top of the morning to all longs. Suck it to you WakeUPP LOL Nice couple of announcements this week. Way, way, way better than rodent tests I'd say.  rate and reply

New Press Release - Lexaria Grants Exclusive License to Premier Wellness Science Co., Ltd. for Strategic and Long-Term Partnership in the Japanese Market

Minimum payments due to Lexaria of US$4,527,500 over the first five years to retain exclusivityLexaria to receive royalty revenue from DehydraTECH product salesKELOWNA, BC / ACCESSWIRE / June 2, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global...read article.

New Press Release - Lexaria Grants License to Valcon Medical for the European Market

(TheNewswire) Contract Manufacturing Organization first in Europe to License DehydraTECHLexaria will receive milestone fees and royalty payments from product salesKelowna, British Columbia – TheNewswire - June 2, 2022 – Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:EXXW) (the “Company” or...read article.

IND will transform the future

Let's go on becoming the next GWPH  rate and reply

New Press Release - Lexaria Announces 2022 Annual Meeting Results

KELOWNA, BC / ACCESSWIRE / June 1, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the results of the 2022 Annual Meeting (the "Meeting").On May 31, 2022 at 1:00 p.m. (Pacific Time), the Company held...read article.

REMEMBER when AGpicks (eg pumper) liked lexx?

Furu A fake guru. Someone who claims to have all the knowledge and skills, but demonstrates none. Furu's are thought of as snake oil salesman or a con man. ...read more

Big stuff happening

$LEXX reversal https://t.co/cZE6ecyYOG  rate and reply

New Press Release - Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Delivery Tech Space

NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Nicotine Surges as Smoking Sags.”To hear the AudioPressRelease, please visit: The NetworkNewsAudio News PodcastTo view the full editorial...read article.

New Press Release - Lexaria Bioscience Corp. (NASDAQ: LEXX) Offers Breakthrough Delivery Tech in Hot Nicotine Space

NEW YORK, May 25, 2022 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing...read article.